DrugCite
Search

THYMOGLOBULIN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Thymoglobulin Adverse Events Reported to the FDA Over Time

How are Thymoglobulin adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Thymoglobulin, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Thymoglobulin is flagged as the suspect drug causing the adverse event.

Most Common Thymoglobulin Adverse Events Reported to the FDA

What are the most common Thymoglobulin adverse events reported to the FDA?

Pyrexia
723 (3.36%)
Febrile Neutropenia
344 (1.6%)
Acute Graft Versus Host Disease
260 (1.21%)
Acute Graft Versus Host Disease In ...
248 (1.15%)
Multi-organ Failure
238 (1.11%)
Serum Sickness
237 (1.1%)
Sepsis
233 (1.08%)
Diarrhoea
227 (1.06%)
Hypotension
225 (1.05%)
Cytomegalovirus Infection
224 (1.04%)
Pneumonia
199 (.93%)
Show More Show More
Chills
193 (.9%)
Kidney Transplant Rejection
182 (.85%)
Cytomegalovirus Test Positive
180 (.84%)
Transplant Rejection
174 (.81%)
Graft Versus Host Disease
168 (.78%)
Nausea
168 (.78%)
Blood Creatinine Increased
164 (.76%)
Infection
153 (.71%)
Dyspnoea
151 (.7%)
Renal Failure
147 (.68%)
Respiratory Failure
147 (.68%)
Alanine Aminotransferase Increased
145 (.67%)
Pulmonary Oedema
144 (.67%)
Renal Failure Acute
142 (.66%)
Chronic Graft Versus Host Disease
140 (.65%)
Vomiting
139 (.65%)
White Blood Cell Count Decreased
138 (.64%)
Aspartate Aminotransferase Increase...
137 (.64%)
Epstein-barr Virus Associated Lymph...
137 (.64%)
Thrombocytopenia
137 (.64%)
Platelet Count Decreased
132 (.61%)
Tachycardia
128 (.6%)
Liver Disorder
126 (.59%)
Epstein-barr Virus Infection
121 (.56%)
Hypertension
121 (.56%)
Thrombotic Microangiopathy
117 (.54%)
Rash
110 (.51%)
Neutropenia
109 (.51%)
Disseminated Intravascular Coagulat...
105 (.49%)
Complications Of Transplanted Kidne...
103 (.48%)
Oxygen Saturation Decreased
103 (.48%)
Anaemia
101 (.47%)
Infusion Related Reaction
100 (.47%)
Death
99 (.46%)
Renal Impairment
98 (.46%)
Staphylococcal Sepsis
96 (.45%)
Acute Graft Versus Host Disease In ...
93 (.43%)
Leukopenia
92 (.43%)
Staphylococcal Infection
92 (.43%)
Headache
91 (.42%)
Therapeutic Response Decreased
91 (.42%)
Blood Bilirubin Increased
90 (.42%)
Arthralgia
87 (.4%)
Cytokine Release Syndrome
86 (.4%)
Hypoxia
86 (.4%)
Drug Ineffective
85 (.4%)
Engraft Failure
84 (.39%)
Bronchopulmonary Aspergillosis
83 (.39%)
Cerebral Haemorrhage
82 (.38%)
Septic Shock
81 (.38%)
Acute Myeloid Leukaemia Recurrent
80 (.37%)
Cystitis Haemorrhagic
80 (.37%)
Liver Transplant Rejection
79 (.37%)
Oedema
79 (.37%)
Pancytopenia
78 (.36%)
Cytomegalovirus Viraemia
76 (.35%)
Convulsion
74 (.34%)
Respiratory Distress
74 (.34%)
Acute Respiratory Distress Syndrome
73 (.34%)
Hepatic Function Abnormal
72 (.33%)
Pleural Effusion
71 (.33%)
Blood Pressure Decreased
70 (.33%)
Disease Progression
70 (.33%)
Aplastic Anaemia
69 (.32%)
Cardiac Failure
66 (.31%)
Atrial Fibrillation
65 (.3%)
Interstitial Lung Disease
64 (.3%)
Pruritus
63 (.29%)
Renal Tubular Necrosis
63 (.29%)
Haemodialysis
61 (.28%)
Abdominal Pain
60 (.28%)
Cardiac Arrest
57 (.27%)
Mucosal Inflammation
56 (.26%)
Transplant Failure
56 (.26%)
Blood Lactate Dehydrogenase Increas...
55 (.26%)
Hepatic Failure
54 (.25%)
Pain
54 (.25%)
Acute Graft Versus Host Disease In ...
53 (.25%)
Hypokalaemia
52 (.24%)
Myalgia
52 (.24%)
Stomatitis
52 (.24%)
Venoocclusive Disease
52 (.24%)
Shock
51 (.24%)
Bacterial Infection
50 (.23%)
Gastrointestinal Haemorrhage
50 (.23%)
Myelodysplastic Syndrome
50 (.23%)
Urinary Tract Infection
50 (.23%)
Aspergillosis
49 (.23%)
Decreased Appetite
49 (.23%)
Herpes Zoster
47 (.22%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Thymoglobulin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Thymoglobulin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Thymoglobulin

What are the most common Thymoglobulin adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Thymoglobulin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Thymoglobulin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Thymoglobulin According to Those Reporting Adverse Events

Why are people taking Thymoglobulin, according to those reporting adverse events to the FDA?

Bone Marrow Conditioning Regimen
1024
Aplastic Anaemia
592
Renal Transplant
517
Prophylaxis Against Transplant Reje...
485
Stem Cell Transplant
240
Kidney Transplant Rejection
151
Show More Show More
Acute Graft Versus Host Disease
147
Prophylaxis Against Graft Versus Ho...
126
Liver Transplant
100
Bone Marrow Transplant
81
Immunosuppression
76
Product Used For Unknown Indication
75
Drug Use For Unknown Indication
66
Transplant Rejection
62
Myelodysplastic Syndrome
56
Acute Myeloid Leukaemia
44
Immunosuppressant Drug Therapy
43
Heart Transplant Rejection
38
Graft Versus Host Disease
37
Heart Transplant
37
Transplant
33
Surgical Preconditioning
32
Cord Blood Transplant Therapy
32
Premedication
30
Pancreas Transplant
27
Liver Transplant Rejection
21
Renal And Pancreas Transplant
19
Bone Marrow Failure
17
Multiple Myeloma
17
Allogenic Bone Marrow Transplantati...
17
Pancreas Transplant Rejection
14
Prophylaxis
14
Acute Lymphocytic Leukaemia
13
Acute Lymphocytic Leukaemia Recurre...
11
Haematological Malignancy
11
Organ Transplant
9
Chronic Lymphocytic Leukaemia
8
Non-hodgkins Lymphoma
8
Type 1 Diabetes Mellitus
7
Intestine Transplant Rejection
7
Lung Transplant
7
Complications Of Transplanted Kidne...
7
Congenital Aplastic Anaemia
6
Intestinal Transplant
5
Pancreas Islet Cell Transplant
5
Chronic Graft Versus Host Disease
4
Histiocytosis Haematophagic
4
Preoperative Care
4
Lung Transplant Rejection
4
Unrelated Donor Bone Marrow Transpl...
4
Renal Failure Chronic
4

Drug Labels

LabelLabelerEffective
ThymoglobulinGenzyme Corporation10-NOV-08

Thymoglobulin Case Reports

What Thymoglobulin safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Thymoglobulin. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Thymoglobulin.